UC Surplus Management Sale is Saturday
From vehicles to laptop computers, the February UC Surplus Management sale is chock-full of some of its most sought-after of items.
The monthly sale takes place from 9 a.m. to 1 p.m. Saturday, Feb. 6, at
.
Feature sale items this month are:
- 5 vehicles & 1 asphalt sealer - see the UC Surplus Management website for vehicle prices and miles
- Laptop and desktop computers - all computers are sold without hard drives
- Metal shelving units
- Projection screens at $15 and up
- Juki sewing machine
- Ping pong table
- Vertical map/chart cabinets
- Wood display case with glass front
- 12 foot wood conference table
- 22 piece skid of computers, $200
- Unique lab and scientific equipment
- 8 foot step ladder
- Selection of 5 ft folding tables
- Bar stools
- Lab glass
- Computer monitors at $25
- Selection of lounge chairs, couches, tables with matching chairs
- Books and Books and Books in our Surplus Management library on sale this month, 4 for $1
- Office chairs, desks, tables, book shelves, filing cabinets and a huge supply of unique UC Surplus inventory.
Purchases can be made via check, credit card (Visa, Master Card,
Discover) or money order, but no cash is accepted. UC Surplus
Management now uses new chip-enabled credit card readers.
For more information and photos of some of the items for this months sale, go to the
or
.
Related Stories
2026 Cincinnati Business Courier's '40 Under 40' includes nine UC alumni
August 3, 2026
Nine remarkable University of Cincinnati alumni have been named by the Cincinnati Business Courier to its annual “40 Under 40” Class for 2026.
As Crosley Tower comes down, UC looks to STEM
July 30, 2026
With demolition of Crosley Tower more than halfway complete, the University of Cincinnati is preparing a, 200,000-square-foot STEM Academic Facility on its Uptown campus, transforming the north side of campus with new classrooms and labs.
UC launches trial to reduce radiation for HPV-positive throat cancer
July 30, 2026
UC radiation oncologist Sara Medek is leading a phase II clinical trial testing whether patients with HPV-positive throat cancer can safely receive lower radiation doses to reduce side effects.